Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-07-02Clinical Trial Update: Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer [Phase 3]
An EORTC Phase 3 trial evaluated chemotherapy followed by either surgery or radiation therapy in patients with stage III non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2012-06-29Clinical Trial Update: K-RAS Oncogene Mutation in Patients With Advanced Non-Small Cell Lung Cancer Associated With Exposure to Wood Smoke and Tobacco Smoking: Therapeutic Implications
The trial update discusses K-RAS mutations in patients with advanced non-small cell lung cancer who have exposure to wood smoke and tobacco,…
-
CLINICAL_TRIALS trial_result · 2012-06-28Clinical Trial Update: Surgery Combined With rAd-p53 Gene in Treatment Advanced Non-small-cell Carcinoma [Phase 2]
An update on a Phase 2 trial evaluating surgery combined with rAd-p53 gene therapy for advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2012-06-28Clinical Trial Update: Clinical Trial of the Safety and Effectiveness of CHR-2797 With Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial of CHR-2797 in combination with erlotinib for locally advanced or metastatic non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2012-06-28Clinical Trial Update: An Open-Label Study of QD Oral Administration of Tivozanib (AV-951) in Subjects With Non-Small Cell Lung Cancer (NSCLC) [Phase 1]
Open-label Phase 1 study of once-daily oral tivozanib (AV-951) in subjects with non-small cell lung cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-06-27Clinical Trial Update: Phase I Imaging Study Evaluating Gem/Cis or Gem/Carbo for Participants With Non-Small Cell Lung Cancer (MK-0000-083 AM3) [Phase 1]
Phase I imaging study evaluating gemcitabine/cisplatin or gemcitabine/carboplatin in participants with non-small cell lung cancer; study com…
-
CLINICAL_TRIALS trial_result · 2012-06-27Clinical Trial Update: Randomized Trial of Docetaxel and Gemcitabine Versus Gemcitabine in Elderly Patients With NSCLC [Phase 3]
A Phase 3 randomized trial comparing docetaxel plus gemcitabine versus gemcitabine alone in elderly patients with non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2012-06-26Clinical Trial Update: Enhancing Adherence and Knowledge of Erlotinib in Patients Wtih Non-Small Cell Lung Cancer [NA]
A completed clinical trial evaluating strategies to enhance adherence and knowledge of erlotinib in patients with non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2012-06-22Clinical Trial Update: A Study In Patients Who Will Undergo Surgical Removal Of Non-Small Cell Lung Cancer To Evaluate Molecular Changes That Occur In Tumor Tissue After Short Term Exposure To PF-00299804 [Phase 1]
A Phase 1 study of PF-00299804 (dacomitinib) in patients with Non-Small Cell Lung Cancer to evaluate molecular changes after short-term expo…
-
CLINICAL_TRIALS trial_result · 2012-06-20Clinical Trial Update: Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers [Phase 2]
Phase 2 trial evaluating intercalated PamCis with Gefitinib or with placebo as first-line therapy for never-smoker patients with non-small c…
-
CLINICAL_TRIALS trial_result · 2012-06-15Clinical Trial Update: Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic Chemotherapy [Phase 2]
Phase 2 study evaluating topotecan with bevacizumab in stage IIIB/IV non-small cell lung cancer after prior chemotherapy; results completed …
-
CLINICAL_TRIALS trial_result · 2012-06-14Clinical Trial Update: Pilot Study for Evaluating the Role of F-18 FLT PET/CT in Therapeutic Decision Making in Non-small Cell Lung Cancer
Pilot study evaluating the role of F-18 FLT PET/CT in guiding therapeutic decisions for non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2012-06-13Clinical Trial Update: Pemetrexed Disodium and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating pemetrexed disodium in combination with gemcitabine for stage IIIB/IV non-small cell lung cancer completed…
-
CLINICAL_TRIALS trial_result · 2012-06-11Clinical Trial Update: Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer [Phase 2]
This update reports the completion of a Phase 2 trial evaluating celecoxib for early-stage head and neck cancer or non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: Randomized Study Of CP-675,206 or Best Supportive Care Immediately After Platinum-Based Therapy For Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 randomized trial comparing CP-675,206 to best supportive care after platinum-based therapy in non-small-cell lung cancer. The study …
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: ZD4054 (Zibotentan) Phase II Non-Small Cell Lung Cancer Study [Phase 2]
Phase II study results for Zibotentan (ZD4054) in non-small cell lung cancer; the trial completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Iressa as Second Line Therapy in Advanced NSCLC-Asia [Phase 3]
Phase 3 clinical trial update showing Iressa as second-line therapy for advanced non-small cell lung cancer in Asia; study completed.
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Carboplatin Plus Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer [Phase 1, Phase 2]
This clinical trial update covers the use of carboplatin plus vinorelbine for stage IIIB or IV non-small cell lung cancer in Phase 1/Phase 2…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer [Phase 1, Phase 2]
This clinical trial update reports on a Phase 1/Phase 2 study of combination chemotherapy plus radiation therapy for stage III non-small cel…
-
CLINICAL_TRIALS trial_result · 2012-06-05Clinical Trial Update: Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases [Phase 2]
Phase 2 trial evaluates radiation therapy plus gefitinib or temozolomide in patients with non-small cell lung cancer and brain metastases; t…
-
CLINICAL_TRIALS trial_result · 2012-06-05Clinical Trial Update: Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial update evaluating gefitinib as first-line therapy followed by gemcitabine and cisplatin in patients with stage III or stage …
-
CLINICAL_TRIALS trial_result · 2012-05-31Clinical Trial Update: Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated first-line therapy with carboplatin and paclitaxel plus TLK286 (Telcyta) in advanced non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: Phase I/II Trial of RAD001 Plus Docetaxel in Patients With Metastatic or Recurrent Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase I/II trial of RAD001 (everolimus) plus docetaxel in metastatic or recurrent non-small cell lung cancer was terminated with results pos…
-
CLINICAL_TRIALS trial_result · 2012-05-24Clinical Trial Update: Safety and Efficacy Study of Icotinb in Non-small Cell Lung Cancer (NSCLC) Patients [Phase 3]
Phase 3 study of icotinib in non-small cell lung cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2012-05-23Clinical Trial Update: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Vinorelbine as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
A Phase III randomized trial evaluating Tariquidar plus Vinorelbine as first-line therapy for stage IIIb/IV non-small cell lung cancer was t…